Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-07-23

Clinical Trial Update: Study Evaluating the Effects of AIR645 on Allergen-Induced Airway Responses in Subjects With Mild Atopic Asthma [Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 2 study evaluating AIR645 for allergen-induced airway responses in adults with mild atopic asthma, which has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AIR645

Snippet

Sponsor: Altair Therapeutics, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED